Jonathan Lim, M.D., is a physician-turned-venturepreneur who has founded, funded and led multiple biotechnology startups that have brought life-changing therapeutics to patients globally while collectively generating approximately $10 billion in shareholder value. Jonathan joined ARCH Venture Partners in December 2018 to help build impactful companies founded on exceptional science, such as Erasca, which he co-founded in July 2018 with the mission to erase cancer and serves as Chairman, CEO, and Co-Founder; Boundless Bio, where he is Chairman and Co-Founder; and Maze Therapeutics, where he is a Board Director. He also is the Managing Partner and Founder of City Hill Ventures.